---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-114226"
form_type: "8-K"
ticker: "OGN"
cik: "0001821825"
company_name: "Organon & Co."
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T09:47:36.736967+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Organon Q3 revenues $1.54B (-4% YoY); raises FY adjusted EBITDA margin guidance

## Summary
- Q3 revenue $1,537M, down 4% YoY as-reported but up 3% ex-FX.
- GAAP diluted EPS $0.89, non-GAAP adjusted diluted EPS $1.32.
- Women's Health revenue grew 19% (23% ex-FX) on Nexplanon demand.
- Full year 2022 revenue guidance narrowed to $6.1-$6.2B; adjusted EBITDA margin raised to 33.5%-34.5%.
- Board declares quarterly dividend of $0.28 per share.

## SEC filing metadata
- accession: 0001104659-22-114226
- form_type: 8-K
- ticker: OGN
- cik: 0001821825
- company_name: Organon & Co.
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1821825/000110465922114226/0001104659-22-114226-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1821825/000110465922114226/tm2229543d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-114226
- JSON: https://secwatch.observer/filing/0001104659-22-114226.json
- Plain text: https://secwatch.observer/filing/0001104659-22-114226.txt

## Key facts
- Earnings Releases
  Organon & Co. reported the third quarter ended September 30, 2022 results: revenue $1,537 million, net income 227, EPS $0.89.
  - Period: the third quarter ended September 30, 2022
  - Revenue: $1,537 million
  - Net income: 227
  - EPS: $0.89
  - Result: reported results
  source text: Halchak (614) 314-8094 Kate Vossen (732) 675-8448 (201) 275-2711 Organon rep orts results for the third quarter ended September 30, 2022 · Third quarter 2022 revenues of $1,537 million · Third quarter diluted earnings per share from continuing operations of $0.89 and non-GAAP adjusted diluted earnings per share from continuing operations of $1.32 · Both
  evidence_url: https://www.sec.gov/Archives/edgar/data/1821825/000110465922114226/0001104659-22-114226-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.